In the present study, we found that an increase in glucose uptake ability as a result of SHIP2 inhibition, which is closely associated with HBV infection in HCC cells, may increase the resistance of these cells to 5-FU (Figure 6F). Here, INPPL1 is linked to hepatocellular carcinoma.